TABLE 1.
Summary of patient demographics
| Demographic | Retrospective samples | Prospective samplesc |
|---|---|---|
| No. of patients | 54 | 151 |
| Median age (range, yrs) | 43a (6–88) | 29 (1 days to 79) |
| No. of female patients (% of total samples) | 37 (68.5) | 121 (80.1) |
| No. of pregnant patients (% of females) | 7 (18.9) | 79 (65.2) |
| Reported travel to or residence in area with local Zika virus transmission (% of total samples) | 54 (100) | 138 (91.4) |
| No. of symptomatic patients (% of total samples)b | 50 (92.6) | 73 (48.3) |
| No. of patients with Fever (%) | 45 (90) | NAd |
| No. of patients with Rash (%) | 42 (84) | NA |
| No. of patients with Conjunctivitis (%) | 28 (56) | NA |
| No. of patients with Arthralgia (%) | 30 (60) | NA |
| No. of patients with GBSe (%) | 7 (14) | NA |
a
Age was not documented for 1 patient.
b
Symptomatic defined as presenting with at least one of the following symptoms: fever, conjunctivitis, rash, arthralgia, Guillain-Barré syndrome.
c
Patient travel and symptom data acquired from ask at order entry questions answered by physician upon order entry. Detailed information regarding travel and specific symptoms was not provided.
d
NA, not available.
e
GBS, Guillain-Barré syndrome.